111 Capital Invests $1.13 Million in CVS Health Corporation $CVS

111 Capital acquired a new stake in CVS Health Corporation (NYSE:CVS) in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 14,952 shares of the pharmacy operator’s stock, valued at approximately $1,127,000.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Y Intercept Hong Kong Ltd bought a new stake in CVS Health in the second quarter valued at approximately $1,228,000. Savvy Advisors Inc. lifted its position in shares of CVS Health by 57.3% in the 2nd quarter. Savvy Advisors Inc. now owns 5,493 shares of the pharmacy operator’s stock worth $379,000 after purchasing an additional 2,001 shares during the period. Atria Investments Inc boosted its stake in shares of CVS Health by 7.0% in the 2nd quarter. Atria Investments Inc now owns 73,684 shares of the pharmacy operator’s stock valued at $5,083,000 after purchasing an additional 4,795 shares during the last quarter. AlphaStar Capital Management LLC acquired a new stake in shares of CVS Health during the second quarter worth $385,000. Finally, GHP Investment Advisors Inc. raised its stake in CVS Health by 11.4% during the second quarter. GHP Investment Advisors Inc. now owns 63,311 shares of the pharmacy operator’s stock worth $4,367,000 after buying an additional 6,476 shares during the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on CVS. JPMorgan Chase & Co. increased their price target on CVS Health from $93.00 to $101.00 and gave the stock an “overweight” rating in a report on Wednesday, December 17th. Barclays upped their target price on CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a research report on Wednesday, December 10th. The Goldman Sachs Group raised their target price on CVS Health from $95.00 to $97.00 and gave the stock a “buy” rating in a research note on Thursday, February 12th. Morgan Stanley boosted their price target on CVS Health from $89.00 to $93.00 and gave the company an “overweight” rating in a research note on Wednesday, December 10th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of CVS Health in a research report on Monday, December 29th. Nineteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $94.91.

CVS Health Price Performance

Shares of CVS opened at $79.74 on Monday. The business’s fifty day moving average is $78.39 and its 200 day moving average is $77.29. CVS Health Corporation has a 12-month low of $58.35 and a 12-month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The stock has a market cap of $101.44 billion, a P/E ratio of 57.78, a P/E/G ratio of 0.83 and a beta of 0.49.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.09. CVS Health had a net margin of 0.44% and a return on equity of 11.31%. The firm had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. The business’s revenue was up 8.2% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.19 earnings per share. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, February 2nd. Shareholders of record on Thursday, January 22nd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend was Thursday, January 22nd. CVS Health’s payout ratio is currently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.